Dr. Kapil Mishra, MD

Dr. Mishra practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Mishra's NPI, 1790149896, was assigned on April 5, 2016. Dr. Mishra graduated from Icahn School Of Medicine At Mount Sinai in 2016. Dr. Mishra holds California license A168327.

Dr. Mishra's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Mishra's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dr. Mishra is also affiliated with Hoag Hospital Newport Beach. The medical group on file is UCI Health Family Health Center, Anaheim. Dmand AI also links Dr. Mishra to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mishra practices, 3 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Mishra's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Mishra is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Mishra's licenses on file in 2 states: California and Maryland.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, glaucoma, laser destruction of retinal or choroid lesions, retinal detachment, retinal occlusion and surgical retina and vitreous procedures among the conditions Dr. Mishra treats.

CMS data shows 2,978 Medicare services from Dr. Mishra across 10 procedure codes in 2024, for 655 Medicare patients. Medicare paid $157,618 for them.

CMS counts 655 Medicare patients who saw Dr. Mishra in 2024. The largest group is 65 to 74, with 272 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mishra's median patient age at 68, with 49% women.

In 2024, Dr. Mishra wrote 481 Medicare Part D claims for 106 patients. 52% of them were for generic drugs. CMS names the drug for 378 of them, across 11 drugs with 11 or more claims each, at $24,672 in total drug cost. In 2023, CMS named 59 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mishra for performance year 2024, reported through an alternative payment model (APM). Dr. Mishra accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 44 papers to Dr. Mishra, published from 2017 to 2025. 2022 was the busiest year, with 10. The most frequent topics are COVID-19, Pandemics and Eye Diseases. Dr. Mishra has published most often in Am J Ophthalmol Case Rep. Dr. Mishra's most frequent co-authors are Prithvi Mruthyunjaya, MD, Irmak Karaca, MD and Vinit Bharati Mahajan, MD, PhD.

CMS Open Payments shows 86 general payments to Dr. Mishra from 22 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 53% of the total. Abbvie Inc. paid the most, $6,313. It also lists 10 research payments totaling $1,893 in 2025, naming 1 clinical trial.

Dr. Mishra graduated from Icahn School Of Medicine At Mount Sinai in 2016.

Dr. Mishra is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.